MEDNAX INCInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
-$4.0M
Buys minus sales2026.06.22
Latest Form 417
Reporting entitiesNo buyer detected
No open-market buysWeis Shirley A
$855.7KAutomated_Intelligence_Report :: MD
Algorithmic analysis of recent insider trading activity for MD reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 17 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $6.50M.
Market dynamics show a negative net capital flow of $4.04M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.
From a microstructural perspective, the most significant liquidity event was a divestment by Weis Shirley A (Officer/Other), which accounts for a major share of the recent outflow. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of MD.
$6.50M
USD NOMINAL VALUE17
UNIQUE C-SUITE ENTITIES2026.06.22
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>Are MD insiders selling their shares?
Yes, we have tracked $4.04M in recent insider liquidations. The most notable recent seller is Weis Shirley A, who executed the largest single offload.
>What is the overall insider sentiment for MD?
The short-term structural capital flow indicates a BEARISH sentiment, with a net flow of $4.04M generated by 17 active C-Suite entities.
>When was the latest SEC Form 4 filed for MD?
The most recent insider transaction on record was filed on 2026.06.22. InsiderAlpha monitors EDGAR filings and updates this terminal as new Form 4 documents are published.